Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China
· Delayed Price · Currency is CNY 4.190
+0.010 (0.24%)
Mar 10, 2026, 3:00 PM CST
SHA:600488 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,575 | 4,630 | 5,360 | 4,835 | 5,051 | 5,427 | Upgrade
|
| Market Cap Growth | -3.01% | -13.63% | 10.87% | -4.27% | -6.93% | 19.48% | Upgrade
|
| Enterprise Value | 5,524 | 5,390 | 6,655 | 6,489 | 7,011 | 6,973 | Upgrade
|
| Last Close Price | 4.19 | 4.14 | 4.68 | 4.20 | 4.36 | 4.67 | Upgrade
|
| PE Ratio | 280.27 | 34.69 | 45.79 | 136.56 | 103.78 | 159.71 | Upgrade
|
| Forward PE | - | 70.80 | 70.80 | 70.80 | 70.80 | 70.80 | Upgrade
|
| PS Ratio | 1.59 | 1.44 | 1.42 | 1.31 | 1.35 | 1.74 | Upgrade
|
| PB Ratio | 1.17 | 1.19 | 1.43 | 1.29 | 1.32 | 1.44 | Upgrade
|
| P/TBV Ratio | 1.74 | 1.71 | 2.02 | 1.78 | 1.80 | 1.89 | Upgrade
|
| P/FCF Ratio | 57.78 | 9.42 | 8.25 | 10.71 | - | - | Upgrade
|
| P/OCF Ratio | 30.83 | 8.13 | 6.85 | 7.40 | 15.94 | 15.65 | Upgrade
|
| EV/Sales Ratio | 1.92 | 1.68 | 1.76 | 1.76 | 1.87 | 2.24 | Upgrade
|
| EV/EBITDA Ratio | 11.05 | 9.64 | 14.76 | 14.81 | 18.30 | 19.28 | Upgrade
|
| EV/EBIT Ratio | 28.03 | 19.96 | 36.99 | 35.78 | 39.35 | 39.17 | Upgrade
|
| EV/FCF Ratio | 69.76 | 10.96 | 10.24 | 14.38 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.14 | 0.25 | 0.37 | 0.37 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 1.44 | 0.95 | 2.11 | 3.20 | 3.67 | 3.55 | Upgrade
|
| Debt / FCF Ratio | 9.11 | 1.09 | 1.47 | 3.11 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.02 | -0.03 | 0.06 | 0.20 | 0.31 | 0.28 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.16 | -0.19 | 0.52 | 1.72 | 3.07 | 2.87 | Upgrade
|
| Net Debt / FCF Ratio | 0.98 | -0.21 | 0.36 | 1.67 | -21.78 | -9.30 | Upgrade
|
| Asset Turnover | 0.49 | 0.54 | 0.59 | 0.57 | 0.60 | 0.52 | Upgrade
|
| Inventory Turnover | 2.46 | 2.61 | 2.21 | 1.81 | 1.94 | 1.43 | Upgrade
|
| Quick Ratio | 1.17 | 0.92 | 0.68 | 0.51 | 0.43 | 0.41 | Upgrade
|
| Current Ratio | 1.74 | 1.49 | 1.09 | 1.03 | 0.93 | 1.05 | Upgrade
|
| Return on Equity (ROE) | 2.11% | 5.45% | 4.33% | 0.49% | 2.86% | 2.14% | Upgrade
|
| Return on Assets (ROA) | 2.10% | 2.85% | 1.76% | 1.74% | 1.78% | 1.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.10% | 6.39% | 4.10% | 3.82% | 2.65% | 2.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 6.00% | 4.30% | 4.10% | 4.10% | 4.10% | Upgrade
|
| Earnings Yield | 0.36% | 2.88% | 2.18% | 0.73% | 0.96% | 0.63% | Upgrade
|
| FCF Yield | 1.73% | 10.62% | 12.12% | 9.34% | -1.07% | -2.06% | Upgrade
|
| Dividend Yield | 2.34% | 2.36% | 1.86% | 0.24% | 0.32% | 0.21% | Upgrade
|
| Payout Ratio | 534.81% | 92.45% | 40.80% | 170.19% | 119.63% | 238.53% | Upgrade
|
| Buyback Yield / Dilution | 0.37% | 0.01% | 1.13% | -2.31% | 1.33% | -0.28% | Upgrade
|
| Total Shareholder Return | 2.72% | 2.37% | 2.99% | -2.07% | 1.65% | -0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.